CDE ID | CDE Description | * 421 | EDRN Participant ID (Go To: 423) |
* 423 | EDRN Protocol ID (Go To: 422) |
* 422 | EDRN Site ID (Go To: 929) |
* 929 | EDRN Staff ID of the person who collected the data: (Go To: 1219) |
* 1219 | Date of contact (MM/DD/YYYY): (Go To: 1586) |
* 1586 | Presence of prostate adenocarcinoma: (Go To: End of Form) |
| Permissible Values (value): | Malignancy absent (1) |
|
| |
* 975 | Prostate T-Stage, Clinical (Go To: End of Form) |
| Permissible Values (value): | T0 (2) |
|
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
* 1594 | Prostate N-Stage, Clinical (Go To: End of Form) |
| Permissible Values (value): | NX (1) |
|
| |
| |
* 1694 | Prostate M-Stage, Clinical : (Go To: End of Form) |
| Permissible Values (value): | MX (1) |
|
| |
| |
| |
| |
| |
* 2151 | Have you received any treatment for prostate cancer? (Go To: End of Form) |
| Permissible Values (value): | No (0) |
|
| |
| |
* 2148 | Primary cancer treatment(s) received: (Go To: End of Form) |
| Permissible Values (value): | Chemotherapy (1) |
|
| |
| |
| |
| | LHRH agonists or anti-androgens hormone therapy (6) |
|
| | Other hormone therapy (e.g. testosterone patch) (7) |
|
| |
| |
* 2150 | Primary cancer treatment(s) received: (Other, specify) (Go To: 1045) |
* 1045 | Performance status (Which of the following options would you say describes your current performance status?) (Go To: End of Form) |
| Permissible Values (value): | Fully active, able to carry on all pre-disease performance without restriction (0) |
|
| | Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work (1) |
|
| | Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours (2) |
|
| | Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours (3) |
|
| | Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair (4) |
|
* 1307 | Ever had cancer [other than basal/squamous cell skin cancer] confirmed by a doctor? (Have you ever had cancer [other than basal/squamous cell skin cancer] confirmed by a doctor?) (Go To: 2621) |
| Permissible Values (value): | No (0) |
|
| |
* 1341 | Cancer type/location (Go To: 2149) |
| Permissible Values (value): | Bladder (1) |
|
| |
| |
| |
| |
| |
| | Head & neck (mouth, nose, and throat) (8) |
|
| |
| |
| |
| |
| |
| |
| | Lymphoma, including Hodgkins (13) |
|
| |
| |
| |
| |
| |
| | Skin (melanoma, no basal or squamous) (18) |
|
| |
| |
| |
| | Other, specify: (97) (Go To: 1339) |
|
| |
* 1339 | Cancer type/location (Other, specify) (Go To: 2149) |
* 2149 | Has the participant been cancer-free for 5 years or more? (Other than basal/squamous cell skin cancer.) (Go To: End of Form) |
| Permissible Values (value): | Free from all other cancers for 5 years or more (2) |
|
| | Free from all other cancers except basal/squamous skin cancer for 5 years or more (3) |
|
| | Free from all other cancers except superficial (Ta) bladder cancer for 5 years or more (can also have had basal/squamous skin cancer) (4) |
|
| | Have had other cancer in the past 5 years (5) |
|
| |
* 842 | Bladder T-Stage, Clinical (Go To: End of Form) |
| Permissible Values (value): | TX (1) |
|
| |
| |
| |
| |
| |
| |
| |
| |
* 2621 | Timing of diagnosis: (Go To: End of Form) |
| Permissible Values (value): | Within one year (to the day) prior to baseline visit (2) |
|
| | More than one year prior to baseline visit (3) |
|
| |
* 2622 | Timing of biopsy: (Go To: End of Form) |
| Permissible Values (value): | No 10-core biopsy (0) |
|
| |
| | Within one year (to the day) prior to baseline visit (2) |
|
| |
* 2624 | Date of biopsy with at least 10 cores (MM/DD/YYYY): (Go To: 1837) |
* 2623 | Are there a minimum of 2 biopsies, one of which is at or within 2 years prior to baseline visit? (Go To: End of Form) |
| Permissible Values (value): | No (0) |
|
| |
| |
* 2625 | Date of most recent biopsy (MM/DD/YYYY): (Go To: 1837) |
* 1837 | Date of cancer diagnosis (MM/DD/YYYY): (Go To: 1097) |
1097 | Comments (do not include any participant identifiers) (Go To: End of Form) |
2572 | Principal Investigator signature: (Go To: End of Form) |